Your browser doesn't support javascript.
loading
Feasibility evaluation of a blood rotation system for efficient blood product utilization in remote island settings.
Nagai, Kazuhiro; Tomari, Noriyuki; Egawa, Satoko; Koga, Yoshito; Itonaga, Hidehiro; Imanishi, Daisuke; Yoshida, Shinichiro; Kinoshita, Ikuo; Miyazaki, Yasushi; Tanaka, Asashi.
Afiliação
  • Nagai K; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
  • Tomari N; Department of Clinical Laboratory, Nagasaki Goto Chuoh Hospital, Goto, Japan.
  • Egawa S; Japan Red Cross Nagasaki Blood Center, Nagasaki, Japan.
  • Koga Y; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
  • Itonaga H; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
  • Imanishi D; Department of Internal Medicine, Nagasaki Goto Chuoh Hospital, Goto, Japan.
  • Yoshida S; Department of Hematology, NHO Nagasaki Medical Center, Ohmura, Japan.
  • Kinoshita I; Japan Red Cross Nagasaki Blood Center, Nagasaki, Japan.
  • Miyazaki Y; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
  • Tanaka A; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Vox Sang ; 119(6): 548-555, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38566595
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Geographical limitations in remote island medical facilities result in excessive wastage of blood products. To address this, we explored the feasibility of a novel blood rotation system, which enables the return and redelivery of blood products to/from the blood bank while ensuring the management of product quality, including temperature control. This study aimed to enhance the supply of blood products to these facilities. MATERIALS AND

METHODS:

The Japan Red Cross Nagasaki Blood Center, Nagasaki Goto Chuoh Hospital (NGCH) and Nagasaki University Hospital collaborated to coordinate the transport and supply of red blood cell (RBC) products. Type O, RhD-positive, irradiated RBC products were stored at a precise 4.0 ± 2.0°C in an active transport refrigerator (ATR). After transport from the Japan Red Cross Nagasaki Blood Center to NGCH, RBC products were held for 1 week in the ATR, and unused products were returned. Eligible returned products were reissued to the Nagasaki University Hospital.

RESULTS:

All the returned RBC products met the redelivery criteria. Among the 103 redelivered RBC preparations, 101 bags (98.1%) were successfully used. NGCH utilized 597 RBC products and discarded 80 samples. The ATR supplied 107 type O RBC bags without any wastage. The overall wastage rate was 10.2% during the study period compared with 24.2% in the same period in the previous year.

CONCLUSION:

This innovative supply and operation system ensures a consistent and secure RBC product supply to remote islands while maximizing blood product use.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article